Smith & Nephew (SNN) Cash from Financing Activities (2009 - 2024)

Smith & Nephew (SNN) reported Cash from Financing Activities of $372.0 million for Q4 2024, up 532.56% on a YoY basis from $58.8 million in Q1 2024, and up 532.56% quarter-over-quarter from -$86.0 million in Q4 2023.

Smith & Nephew (SNN) Cash from Financing Activities (2009 - 2024) Analysis & Trends

Smith & Nephew has reported Cash from Financing Activities for 16 years, with the latest figure at $372.0 million in Q4 2024.

  • For the quarter ending Q4 2024, Cash from Financing Activities rose 532.56% year-over-year to $372.0 million; the trailing twelve-month figure through Dec 2024 stood at -$720.0 million (up 6.13% YoY), and the FY2025 full-year result was -$955.0 million, down 1010.47% from the prior year.
  • Cash from Financing Activities for Q4 2024 stood at $372.0 million, up from -$86.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $372.0 million in Q4 2024, with the low at -$704.0 million in Q4 2022.
  • Historically, Cash from Financing Activities has averaged -$79.0 million across 5 years, with a median of -$86.0 million in 2023.
  • Annual changes were most pronounced in 2021 — Cash from Financing Activities slumped 192.92% — and 2024, when it jumped 532.56%.
  • Smith & Nephew's Cash from Financing Activities stood at $325.0 million in 2020, then tumbled by 192.92% to -$302.0 million in 2021, then sank by 133.11% to -$704.0 million in 2022, then surged by 87.78% to -$86.0 million in 2023, then jumped by 532.56% to $372.0 million in 2024.
  • The last three Cash from Financing Activities figures came in at $372.0 million (Q4 2024), -$86.0 million (Q4 2023), and -$704.0 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Smith & Nephew 5.27 Bn 4.69 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 372.00 Mn
Dec 31, 2024 372.00 Mn
Dec 31, 2023 -86.00 Mn
Dec 31, 2023 -86.00 Mn
Dec 31, 2022 -704.00 Mn
Dec 31, 2022 -704.00 Mn
Dec 31, 2021 -302.00 Mn
Dec 31, 2021 -302.00 Mn
Dec 31, 2020 325.00 Mn
Dec 31, 2020 325.00 Mn
Dec 31, 2019 303.00 Mn
Dec 31, 2019 303.00 Mn
Dec 31, 2018 -371.00 Mn
Dec 31, 2018 -371.00 Mn
Dec 31, 2017 -434.00 Mn
Dec 31, 2017 -434.00 Mn
Dec 31, 2016 -529.00 Mn
Dec 31, 2016 -529.00 Mn
Dec 31, 2015 -558.00 Mn
Dec 31, 2015 -558.00 Mn